Yahoo Malaysia Web Search

Search results

  1. Jun 20, 2024 · Paul Hudson, CEO of Sanofi, works in a volatile business. The pharma sector has been very profitable for many decades, and its weight in the economy has grown steadily.

  2. Jun 20, 2024 · Paul Hudson, CEO of Sanofi, works in a volatile business. The pharma sector has been very profitable for many decades, and its weight in the economy has grown steadily.

  3. 5 days ago · July 03, 2024 at 04:01 pm EDT. Paul Hudson, CEO of Sanofi, discusses the use of artificial intelligence (AI) technology in the company's operations. Sanofi is focused on discovering new medicines and improving organisational efficiency through AI. The company uses advanced language models and partnerships with companies such as OpenAI and ...

  4. 5 days ago · Sanofi CEO Paul Hudson discusses AI's impact for the biopharmaceutical industry He spoke to Bloomberg's Caroline Hyde. Jul 03, 2024

  5. 5 days ago · Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug ...

  6. Jun 20, 2024 · As you’ll read from Hudsons answers below, the British CEO has been doubling down on his AI implementation, and it’s starting to pay off—Sanofi today is becoming a leader in AI. This ...

  7. 5 days ago · Paul Hudson, Chief Executive Officer at Sanofi, said, "With today's approval of Dupixent, we can change the treatment landscape for the more than 200,000 patients throughout the EU living with...